Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells

Oncogene

Volumn 12, Issue 7, 1996, Pages 1571-1576

  Gao, Chuan ^a   Arlinghaus, Ralph B ^a   Singh, Balraj ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

c mos expression; Cell cycle control; Transcriptional regulation

Indexed keywords

LUCIFERASE; RIBONUCLEASE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GERM CELL; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTO ONCOGENE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL CYCLE; DNA PROBES; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-MOS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0029925087     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Colledge WH, Carlton MBL, Udy GB and Evans MJ. (1994). Nature, 370, 65-68.
2. Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, Okazaki K, Nagayoshi M, Takeda N, Ikawa Y and Aizawa S. (1994). Nature, 370, 68-71.
3. Herzog NK, Ramagli LS, Khorana S and Arlinghaus RB. (1989). Oncogene, 4, 1307-1315.
4. Herzog NK, Singh B, Elder J, Lipkin I, Trauger RJ, Millette CF, Goldman DS, Wolfes H, Cooper GM and Arlinghaus RB. (1988). Oncogene, 3, 225-229.
5. Jang SK and Wimmer E. (1990). Genes and Development, 4, 1560-1572.
6. Jones M, Bosselman RA, van der Hoorn FA, Berns A, Fan H and Verma IM. (1980). Proc. Natl. Acad. Sci. USA, 77, 2651-2655.
7. Leibovitch SA, Guillier M, Lenormand JL and Leibovitch MP. (1991). Oncogene, 6, 1617-1622.
8. Leibovitch SA, Lenormand JL, Leibovitch MP, Guillier M, Mallard L and Harel J. (1990). Oncogene, 5, 1149-1157.
9. Maxwell S and Arlinghaus R. (1985). Virology, 143, 321-333.
10. McGeady ML, Wood TG, Maizel JV and Vande Woude GF. (1986). DNA, 5, 289-298.
11. Nash M, Brown NV, Wong JL Arlinghaus RB and Murphy Jr, EC. (1984). J. Virol., 50, 478-488.
12. Oskarsson M, McClements WL, Blair DG, Maizel JV and Vande Woude GF. (1980). Science, 207, 1222-1224.
13. Propst F and Vande Woude GF. (1984). Nucleic Acids Res., 12, 8381-8392.
14. Propst F and Vande Woude GF. (1985). Nature, 315, 516-518.
15. Propst F, Rosenberg MP, Iyer A, Kaul K and Vande Woude GF. (1987). Mol. Cell. Biol., 7, 1629-1637.
16. Sagata N, Watanabe N, Vande Woude GF and Ikawa Y. (1989). Nature, 342, 512-518.
17. Tobey RA, Oishi N and Crissman HA. (1990). Proc. Natl. Acad. Sci. USA, 87, 5104-5108.
18. Tsui L. (1993). Ph.D. dissertation. The University of Texas Graduate School of Biomedical Sciences, Houston, TX.
19. Tsui LV, Ramagli LS, Singh B, Nash M and Arlinghaus RB. (1993). Int. J. Oncol., 2, 493-502.
20. Wood TF, McGeady ML, Baroudy BM, Blair DG and Vande Woude GF. (1984). Proc. Natl. Acad. Sci. USA, 81, 7817-7821.
21. Zhao X, Batten B, Singh B and Arlinghaus RB. (1990). Oncogene, 5, 1727-1730.
22. Zhao X, Singh B and Batten B. (1991). Oncogene, 6, 43-49.
23. Zinkel SS, Pal SK, Szeberenyi J and Cooper GM. (1992). Mol. Cell. Biol., 12, 2029-2036.